Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL231813 (Incivek, Incivo, LY 570310, LY-570310, MP 424, MP-424, Telaprevir, VRT 111950, VRT-111950, VX 950, VX-950) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
cathepsin B/Cathepsin B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4072] [GtoPdb: 2343] [UniProtKB: P07858] | ||||||||
ChEMBL | Inhibition of human Cathepsin B | B | 5.36 | pIC50 | 4400 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
ChEMBL | Inhibition of human CatB after 60 mins fluorescence assay | B | 5.64 | pIC50 | 2300 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 4611-4618 [PMID:20823284] |
ChEMBL | Inhibition of cathepsin B | B | 6.68 | pIC50 | 210 | nM | IC50 | J Med Chem (2011) 54: 2529-2591 [PMID:21413808] |
cathepsin F/Cathepsin F in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2517] [GtoPdb: 2347] [UniProtKB: Q9UBX1] | ||||||||
ChEMBL | Inhibition of human Cathepsin F | B | 5 | pIC50 | >10000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
cathepsin K/Cathepsin K in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL268] [GtoPdb: 2350] [UniProtKB: P43235] | ||||||||
ChEMBL | Inhibition of human Cathepsin K | B | 6.2 | pIC50 | 630 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
cathepsin L/Cathepsin L in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3837] [GtoPdb: 2351] [UniProtKB: P07711] | ||||||||
ChEMBL | Inhibition of human Cathepsin L | B | 5.46 | pIC50 | 3500 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
cathepsin V/Cathepsin L2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3272] [GtoPdb: 2352] [UniProtKB: O60911] | ||||||||
ChEMBL | Inhibition of human Cathepsin V | B | 5.87 | pIC50 | 1350 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
cathepsin S/Cathepsin S in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2954] [GtoPdb: 2353] [UniProtKB: P25774] | ||||||||
ChEMBL | Inhibition of human cathepsin S | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
ChEMBL | Inhibition of human Cathepsin S | B | 6.52 | pIC50 | 300 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
chymase 1/Chymase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4068] [GtoPdb: 2340] [UniProtKB: P23946] | ||||||||
ChEMBL | Inhibition of human Chymase | B | 7.59 | pIC50 | 26 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
chymotrypsin like elastase 1/Elastase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3000] [GtoPdb: 2338] [UniProtKB: Q9UNI1] | ||||||||
GtoPdb | - | - | 7.52 | pIC50 | 30 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-11 [PMID:19841155] |
ChEMBL | Inhibition of human Pancreatic elastase 1 | B | 7.52 | pIC50 | 30 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
elastase, neutrophil expressed/Leukocyte elastase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246] | ||||||||
ChEMBL | Inhibition of human Neutrophil elastase 2 | B | 5.1 | pIC50 | 8000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
ChEMBL | Inhibition of human neutrophil elastase | B | 5.1 | pIC50 | 8000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
ChEMBL | Inhibition of human leukocyte elastase after 60 mins fluorescence assay | B | 6.17 | pIC50 | 680 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 4611-4618 [PMID:20823284] |
NS3 protease in Hepatitis C virus subtype 1b (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4296325] [UniProtKB: Q0ZMF1] | ||||||||
ChEMBL | Inhibition of full-length HCV NS3 protease A156T mutant | B | 5.21 | pKi | 6100 | nM | Ki | J Med Chem (2014) 57: 1790-1801 [PMID:23517538] |
ChEMBL | Inhibition of full-length HCV NS3 protease R155K mutant | B | 7.09 | pKi | 82 | nM | Ki | J Med Chem (2014) 57: 1790-1801 [PMID:23517538] |
NS3 protease in Hepacivirus C (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4296313] [UniProtKB: C1KIQ2] | ||||||||
ChEMBL | Inhibition of full-length HCV NS3 protease D168V mutant | B | 8.41 | pKi | 3.9 | nM | Ki | J Med Chem (2014) 57: 1790-1801 [PMID:23517538] |
ChEMBL | Inhibition of HCV genotype 1a NS3 protease V36M/R155K double mutant expressed in Escherichia coli BL21 (DE3) | B | 5.47 | pIC50 | 3400 | nM | IC50 | Antimicrob Agents Chemother (2008) 52: 110-120 [PMID:17938182] |
ChEMBL | Inhibition of HCV 1a NS3-4A protease R155S mutant after 60 mins | B | 5.94 | pIC50 | 1150 | nM | IC50 | J Biol Chem (2007) 282: 22619-22628 [PMID:17556358] |
ChEMBL | Inhibition of HCV 1a NS3-4A R155I mutant protease after 60 mins | B | 6.06 | pIC50 | 880 | nM | IC50 | J Biol Chem (2007) 282: 22619-22628 [PMID:17556358] |
ChEMBL | Inhibition of HCV 1a NS3-4A R155K mutant protease after 60 mins | B | 6.29 | pIC50 | 510 | nM | IC50 | J Biol Chem (2007) 282: 22619-22628 [PMID:17556358] |
ChEMBL | Inhibition of HCV 1a NS3-4A R155T mutant protease after 60 mins | B | 6.31 | pIC50 | 490 | nM | IC50 | J Biol Chem (2007) 282: 22619-22628 [PMID:17556358] |
ChEMBL | Inhibition of HCV genotype 1a NS3 protease V36M mutant expressed in Escherichia coli BL21 (DE3) | B | 6.57 | pIC50 | 270 | nM | IC50 | Antimicrob Agents Chemother (2008) 52: 110-120 [PMID:17938182] |
ChEMBL | Inhibition of HCV genotype 1a NS3 protease V36L mutant expressed in Escherichia coli BL21 (DE3) | B | 6.89 | pIC50 | 130 | nM | IC50 | Antimicrob Agents Chemother (2008) 52: 110-120 [PMID:17938182] |
plasminogen/Plasminogen in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1801] [GtoPdb: 2394] [UniProtKB: P00747] | ||||||||
ChEMBL | Inhibition of human plasmin | B | 5.06 | pIC50 | 8700 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
ChEMBL | Inhibition of SARS-CoV-2 3CL protease using Dabcyl-KTSAVLQSGFRKME-Edans substrate measured by flourimetric plate reader method | B | 4.94 | pIC50 | 11470 | nM | IC50 | Bioorg Med Chem Lett (2021) 48: 128263-128263 [PMID:34271072] |
ChEMBL | Inhibition of N-terminal 6His-tagged SARS-CoV-2 3CL protease (3259 to 3569 residues) expressed in Escherichia coli BL21 (DE3) using FRET-based UIVT3 as substrate preincubated for 10 mins followed by substrate addition and measured for 10 mins | B | 4.97 | pIC50 | 10700 | nM | IC50 | RSC Med Chem (2021) 12: 1026-1036 [PMID:34355175] |
ChEMBL | Inhibition of SARS-CoV-2 3CLpro preincubated for 30 mins followed by addition of (Dabcyl)KTSAVLQSGFRKM(Glu) peptide substrate and measured after 1.5 hrs by FRET assay | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2021) 48: 128263-128263 [PMID:34271072] |
coagulation factor II, thrombin/Thrombin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734] | ||||||||
ChEMBL | Inhibition of human thrombin | B | 6 | pIC50 | <1000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 6325-6330 [PMID:24135727] |
serine protease 1/Trypsin I in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL209] [GtoPdb: 2397] [UniProtKB: P07477] | ||||||||
ChEMBL | Inhibition of human Trypsin activity | B | 5 | pIC50 | >10000 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 305-311 [PMID:19841155] |
Cathepsin A in Human [GtoPdb: 1581] [UniProtKB: P10619] | ||||||||
GtoPdb | - | - | 7 | pIC50 | 100 | nM | IC50 | WO2013072328. Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases. (2013) |
CoV 3C-like (main) protease in SARS-CoV-2 [GtoPdb: 3111] | ||||||||
GtoPdb | - | - | 4.94 | pIC50 | 11470 | nM | IC50 | ACS Nano (2021) 15: 857-872 [PMID:33373194] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]